REVIEW   

Minerva Ortopedica e Traumatologica 2014 June;65(3):243-9

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

Management strategies of prosthetic joint infections of the hip

Viste A. ^{1, 2, 3, 4}, Robin J. ^{3, 5, 6}, Laurent F. ^{2, 3, 7}, Ferry T. ^{2, 3, 8}, Lustig S. ^{2, 3, 4, 5} ✉

¹ Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Chirurgie Orthopédique et Traumatologique, Pierre Bénite Cedex, France; ² Université de Lyon, Lyon, France; ³ Université Claude Bernard Lyon 1, Villeurbanne, France; ⁴ IFSTTAR, UMR_T9406, LBMC Laboratoire de Biomécanique et Mécanique des Chocs, Bron, France; ⁵ Chirurgie Orthopédique, Centre Albert Trillat, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Grande Rue de la Croix Rousse, Lyon, France; ⁶ Department of Orthopedic Surgery, Box Hill Hospital, Victoria, Australia; ⁷ Laboratoire de Bactériologie, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France; ⁸ Centre Régional Infections Ostéo‑articulaires, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France

Prosthetic joint infection (PJI) of the hip remains a devastating and costly complication of total hip arthroplasty. The treatment depends on many factors: host comorbidities, the duration of symptoms and the infecting organism. Irrigation and debridement can be performed for acute cases accompanied by modular component exchange. For chronic infections, a single-stage or two-stage revision is possible depending on the patient’s general health. If revision is not possible, antibiotic suppression or a resection arthroplasty (Girdlestone procedure) may be indicated. In all cases, a multidisciplinary team approach must be utilized, coordinated by the orthopedic surgeon and the specialist in infectious diseases. The eradication of infection is essential whilst maintaining optimal hip function.